Inspire Medical Systems
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with...
Latest News
5 days ago · zacks.com
Here's Why You Should Retain INSP Stock in Your Portfolio for NowInspire Medical's strong Inspire V adoption, improving reimbursement clarity and patient access initiatives support growth despite near-term headwinds.
6 days ago · zacks.com
INSP Is Up 12.1% in Three Months: Can Its Rally Continue From Here?Inspire Medical shares have rallied 12.1% in three months, but reimbursement hurdles and weak revenues raise questions about whether the gains can continue.
13 days ago · seekingalpha.com
Inspire Medical Systems: The Moat Just Passed Its Worst-Case Stress TestInspire Medical Systems remains fundamentally strong despite severe reimbursement and coding disruptions, which the market has mispriced as permanent impairment. INSP's gross margin expanded to 86%, and operating cash flow reached $82.5M over nine months, even as revenue declined 7.9% year-over-year due to administrative headwinds. Management attributes nearly all revenue shortfall to coding issues, with growth expected to resume post-2027 as a permanent CPT code takes effect in January 2028.
13 days ago · globenewswire.com
Inspire Medical Systems, Inc. to Present at the Stifel 2026 Healthcare ConferenceMINNEAPOLIS, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Stifel 2026 Healthcare Conference on Tuesday, November 10, 2026. Inspire is scheduled to present at 2:40 p.m.
14 days ago · benzinga.com
These Analysts Increase Their Forecasts On Inspire Medical After Strong Q3 ResultsInspire Medical Systems, Inc. (NYSE:INSP) reported upbeat earnings for the third quarter on Monday.
14 days ago · seekingalpha.com
Inspire Medical Systems, Inc. (INSP) Q3 2026 Earnings Call TranscriptInspire Medical Systems, Inc. ( INSP ) Q3 2026 Earnings Call November 2, 2026 5:00 PM EST Company Participants Timothy Herbert - Founder, Chairman, CEO & President Matthew Osberg - Executive VP & CFO Conference Call Participants Jonathan Block - Stifel, Nicolaus & Company, Incorporated, Research Division Adam Maeder - Piper Sandler & Co., Research Division Robert Marcus - JPMorgan Chase & Co, Research Division Anthony Petrone - Mizuho Securities USA LLC, Research Division Larry Biegelsen - Wells Fargo Securities, LLC, Research Division Richard Newitter - Truist Securities, Inc., Research Division Travis Steed - BofA Securities, Research Division Keith Hinton - Prime Executions, Inc., Research Division Suraj Kalia - Oppenheimer & Co. Inc., Research Division Michael Sarcone - Jefferies LLC, Research Division David Rescott - Robert W. Baird & Co. Incorporated, Research Division Brett Fishbin - KeyBanc Capital Markets Inc., Research Division Michael Kratky - Leerink Partners LLC, Research Division Daniel Markowitz - Evercore ISI Institutional Equities, Research Division Christopher Pasquale Presentation Operator Good afternoon.
14 days ago · marketbeat.com
Inspire Medical Systems Q3 Earnings Call HighlightsInspire Medical Systems NYSE: INSP reported third-quarter revenue of $206.7 million, down 7.9% from a year earlier but up 3% sequentially, as stronger-than-expected U.S. performance offset weaker international results. The company said coding and reimbursement challenges continued to weigh on results, though management expressed growing confidence that the disruption is easing.
14 days ago · zacks.com
Inspire Medical Systems (INSP) Q3 Earnings and Revenues Beat EstimatesInspire Medical Systems (INSP) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.1 per share. This compares to earnings of $0.38 per share a year ago.
14 days ago · zacks.com
Here's What Key Metrics Tell Us About Inspire (INSP) Q3 EarningsThe headline numbers for Inspire (INSP) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
14 days ago · globenewswire.com
Inspire Medical Systems, Inc. Announces Third Quarter 2026 Financial ResultsMINNEAPOLIS, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the Company), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter ended September 30, 2026.
Earnings
Analyst Summary
Add to Watchlist
Select watchlists to add or remove INSP